Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | TAS0728 |
Synonyms | |
Therapy Description |
TAS0728 is a small molecule ERBB2 (HER2) inhibitor, which may have antitumor activity against HER2-amplified tumor models (PMID: 30787176, PMID: 32248641). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
TAS0728 | TAS 0728|TAS-0728|TPC-107 | HER2 Inhibitor 42 | TAS0728 is a small molecule ERBB2 (HER2) inhibitor, which may have antitumor activity against HER2-amplified tumor models (PMID: 30787176, PMID: 32248641). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03410927 | Phase Ib/II | TAS0728 | A Study of TAS0728 in Patients With Solid Tumors With HER2 or HER3 Abnormalities | Terminated | USA | GBR | FRA | ESP | 0 |